[{"indications": "Indications\u00a0immunisation against tick-borne encephalitis", "name": "TICK-BORNE ENCEPHALITIS VACCINE, INACTIVATED", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "14 Immunological products and vaccines", "14.4 Vaccines and antisera", "Tick-borne encephalitis vaccine", "TICK-BORNE ENCEPHALITIS VACCINE, INACTIVATED"], "cautions": "Cautions\u00a0see section 14.1", "side-effects": "Side-effects\u00a0see section 14.1", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/128176.htm", "doses": ["Initial immunisation, by intramuscular injection in deltoid region or anterolateral thigh in infants, adult and child over\r\n16 years, 3 doses each of 0.5\u00a0mL, second dose after 1\u20133 months and\r\nthird dose after further 5\u201312 months; child 1\u201316 years 3 doses of 0.25\u00a0mL, second dose after 1\u20133 months and\r\nthird dose after further 5\u201312 months; elderly over 60 years and immunocompromised (including those receiving immunosuppressants),\r\nantibody concentration may be measured 4 weeks after second dose and\r\ndose repeated if protective levels not achieved", "To achieve more rapid protection, second\r\ndose may be given 14 days after first dose", "Booster doses, give first dose within 3 years after initial\r\ncourse completed, then every 3\u20135 years"], "pregnancy": "Pregnancy\u00a0see section 14.1"}]